- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Morepen Laboratories will hold its 40th Annual General Meeting on September 6, 2025. Shareholders will consider a final dividend of ₹0.20 per equity share for FY 2024-25. The agenda also includes the re-appointment of Mr. Sanjay Suri as Whole-Time Director with an annual remuneration up to ₹7.00 Cr. The company seeks approval to extend the timeline for hiving off its Medical Devices Business into a subsidiary for ₹181.12 Cr, now aimed for completion by the 2026 AGM. Further approvals are sought for annual salaries of up to ₹0.60 Cr for Ms. Aanandi Suri and Mr. Arjun Suri. A key proposal allows converting outstanding loans up to ₹1200 Cr into company shares or other securities.